Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor

Therapeutic Advances in Medical Oncology
Juana Fernández-RodríguezConxi Lázaro

Abstract

The aim of this study was to test the feasibility and utility of developing patient-derived orthotopic xenograft (PDOX) models for patients with malignant peripheral nerve sheath tumors (MPNSTs) to aid therapeutic interventions in real time. A sporadic relapsed MPNST developed in a 14-year-old boy was engrafted in mice, generating a PDOX model for use in co-clinical trials after informed consent. SNP-array and exome sequencing was performed on the relapsed tumor. Genomics, drug availability, and published literature guided PDOX treatments. A MPNST PDOX model was generated and expanded. Analysis of the patient's relapsed tumor revealed mutations in the MAPK1, EED, and CDK2NA/B genes. First, the PDOX model was treated with the same therapeutic regimen as received by the patient (everolimus and trametinib); after observing partial response, tumors were left to regrow. Regrown tumors were treated based on mutations (palbociclib and JQ1), drug availability, and published literature (nab-paclitaxel; bevacizumab; sorafenib plus doxorubicin; and gemcitabine plus docetaxel). The patient had a lung metastatic relapse and was treated according to PDOX results, first with nab-paclitaxel, second with sorafenib plus doxorubicin after progres...Continue Reading

References

Aug 15, 2003·Surgical Oncology Clinics of North America·Courtney L Scaife, Peter W Pisters
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Modesto CarliJoern Treuner
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Dec 15, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andrea FerrariSheri L Spunt
Aug 24, 2011·Annals of Surgical Oncology·Chee-Chee H StuckyNabil Wasif
Aug 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·August VidalAlberto Villanueva
Dec 12, 2012·The Journal of Clinical Investigation·Walter J JessenNancy Ratner
Sep 14, 2014·Cancer Research·Chiara AmbrogioAlberto Villanueva
Jul 15, 2015·Molecular and Clinical Oncology·Amir SonnenblickDaniela Katz
Dec 29, 2016·The New England Journal of Medicine·Eva DombiBrigitte C Widemann
Jan 27, 2017·Genes, Chromosomes & Cancer·Pierre SohierMeena Upadhyaya
Sep 2, 2017·Experimental Neurology·AeRang Kim, Christine A Pratilas
Sep 25, 2017·Cell·Jean-David Rochaix
Nov 9, 2017·Journal of the National Cancer Institute·Karlyne M ReillyDouglas R Stewart
Mar 8, 2018·Oncogene·Sara BolinFredrik J Swartling
Jul 18, 2018·Nature Methods·Sangtae KimChristopher T Saunders
Aug 22, 2018·International Journal of Molecular Sciences·Cristian P MoiolaEva Colas

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts
exome sequencing

Clinical Trials Mentioned

NCT03433183
NCT03524898
NCT03266159
NCT01841463

Software Mentioned

BWA MEM
Strelka

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Jue ZhangYan Li
International Journal of Molecular Sciences
Robert M Hoffman
© 2021 Meta ULC. All rights reserved